⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MAZE News
Maze Therapeutics, Inc. Common Stock
IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
BHVN
NVO
LLY
LXRX
XRTX
REGN
FMS
MDT
AMPH
DRCT
BMRC
MAZE
MazeBolt Named Best AI-Powered Vulnerability Management Solution in 2026 Cybersecurity Stars Awards
globenewswire.com
MAZE
Form 8-K
sec.gov
MAZE
Zifo to Present Biobank Data Breakthrough at the Festival of Genomics Boston
prnewswire.com
MAZE
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
globenewswire.com
MAZE
Form 8-K
sec.gov
MAZE
Form 8-K
sec.gov
MAZE
Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
globenewswire.com
MAZE
Form 8-K
sec.gov
MAZE
Maze Therapeutics Announces $150 Million Registered Offering
globenewswire.com
MAZE